Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials
PaperCitations, authors & open-access status
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 658 citations, 2020 year and green oa status.
658
Citations
2020
Year
green
OA Status